Pediatric hepatobiliary disease.
OBJECTIVE
This review summarizes recent advancements occurring over the past year in the field of pediatric hepatology. They have helped in the understanding and treatment of several liver and biliary tract disorders of childhood.


RESULTS
Recent advancements in the areas of childhood primary sclerosing cholangitis, nonalcoholic fatty liver disease, acute liver failure, liver transplantation, neonatal hemochromatosis, and the Biliary Atresia Research Consortium have been summarized.


CONCLUSIONS
Developments and continued research in these areas have the potential to bring significant benefits to children affected by these disorders.
Pall
Harpreet
H
Division of Gastroenterology, Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
Jonas
Maureen M
MM
D001656:Biliary Atresia / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D002648:Child; D015209:Cholangitis, Sclerosing / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D005234:Fatty Liver / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D006432:Hemochromatosis / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D006801:Humans; D007231:Infant, Newborn; D017114:Liver Failure, Acute / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D016031:Liver Transplantation; D011379:Prognosis